GMO U.S. Opportunistic Value I holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.
Gmo U.S. Opportunistic Value Fund Class I PPAEX
- NAV / 1-Day Return 23.02 / +0.83 %
- Total Assets 338.0M
-
Adj. Expense Ratio
0.610%
- Expense Ratio 0.610%
- Distribution Fee Level Below Average
- Share Class Type No Load
- Category Large Value
- Investment Style Large Value
- Min. Initial Investment 0
- Status Open
- TTM Yield 0.00
- Turnover 72%
USD | NAV as of Jul 10, 2026 | 1-Day Return as of Jul 10, 2026, 11:30 PM GMT+0
Morningstar’s Analysis PPAEX
Will PPAEX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 28.1
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Exxon Mobil Corp | 4.14 | 13M | Energy |
Johnson & Johnson | 3.87 | 12M | Healthcare |
Merck & Co Inc | 3.09 | 10M | Healthcare |
Alphabet Inc Class A | 2.95 | 9M | Communication Services |
Verizon Communications Inc | 2.67 | 9M | Communication Services |
Chevron Corp | 2.43 | 8M | Energy |
Procter & Gamble Co | 2.34 | 7M | Consumer Defensive |
Bank of America Corp | 2.29 | 7M | Financial Services |
Pfizer Inc | 2.27 | 7M | Healthcare |
Comcast Corp Class A | 2.04 | 7M | Communication Services |